Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

The NCDR Left Atrial Appendage Occlusion Registry.

Freeman JV, Varosy P, Price MJ, Slotwiner D, Kusumoto FM, Rammohan C, Kavinsky CJ, Turi ZG, Akar J, Koutras C, Curtis JP, Masoudi FA.

J Am Coll Cardiol. 2020 Mar 13. pii: S0735-1097(20)30089-9. doi: 10.1016/j.jacc.2019.12.040. [Epub ahead of print]

PMID:
32238316
2.

Post-Emergency Department AtrialĀ Fibrillation Clinics: A Shifting Paradigm in Care?

Freeman JV, Ganeshan R.

JACC Clin Electrophysiol. 2020 Jan;6(1):53-55. doi: 10.1016/j.jacep.2019.10.006. No abstract available.

PMID:
31971906
3.

Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation.

Inohara T, Holmes DN, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Hylek EM, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators.

Heart. 2020 Mar;106(5):358-364. doi: 10.1136/heartjnl-2019-315792. Epub 2020 Jan 7.

PMID:
31911503
4.

Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic Medications.

Freeman JV, Tabada GH, Reynolds K, Sung SH, Singer DE, Wang PJ, Liu TI, Gupta N, Hlatky MA, Go AS.

Am J Cardiol. 2020 Feb 15;125(4):553-561. doi: 10.1016/j.amjcard.2019.11.004. Epub 2019 Nov 19.

PMID:
31843233
5.

Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.

Freeman JV, Shrader P, Pieper KS, Allen LA, Chan PS, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel JA, Singer DE, Go AS, Hylek EM, Steinberg BA, Peterson ED, Piccini JP.

Circ Arrhythm Electrophysiol. 2019 Dec;12(12):e007612. doi: 10.1161/CIRCEP.119.007612. Epub 2019 Dec 13.

PMID:
31830822
6.

Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation.

Pokorney SD, Holmes DN, Shrader P, Thomas L, Fonarow GC, Mahaffey KW, Gersh BJ, Kowey PR, Naccarelli GV, Freeman JV, Singer DE, Washam JB, Peterson ED, Piccini JP, Reiffel JA.

Am Heart J. 2020 Feb;220:145-154. doi: 10.1016/j.ahj.2019.09.017. Epub 2019 Oct 23.

PMID:
31812756
7.

Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation.

Loring Z, Shrader P, Allen LA, Blanco R, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Mahaffey KW, Naccarelli GV, Pieper K, Reiffel JA, Singer DE, Steinberg BA, Thomas LE, Peterson ED, Piccini JP.

Am Heart J. 2020 Jan;219:21-30. doi: 10.1016/j.ahj.2019.10.008. Epub 2019 Nov 8.

PMID:
31710841
8.

Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.

Pokorney SD, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Reiffel JA, Singer DE, Freeman JV, Gersh BJ, Mahaffey KW, Hylek EM, Naccarelli GV, Ezekowitz MD, Piccini JP, Peterson ED; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators.

JAMA Cardiol. 2019 Jul 3. doi: 10.1001/jamacardio.2019.1960. [Epub ahead of print]

9.

Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II.

Inohara T, Shrader P, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Go AS, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators.

Am Heart J. 2019 Jul;213:81-90. doi: 10.1016/j.ahj.2019.04.007. Epub 2019 Apr 24.

PMID:
31129441
10.

Digoxin Use and Associated Adverse Events Among Older Adults.

Angraal S, Nuti SV, Masoudi FA, Freeman JV, Murugiah K, Shah ND, Desai NR, Ranasinghe I, Wang Y, Krumholz HM.

Am J Med. 2019 Oct;132(10):1191-1198. doi: 10.1016/j.amjmed.2019.04.022. Epub 2019 May 9.

PMID:
31077654
11.

Atrial Fibrillation Thermographic and Endoscopic Monitoring of Patients: Safety Algorithm for the Esophagus: AF TEMP-SAFE Study.

Hummel JP, Kadado AJ, Baker M, Gehi AK, Mounsey JP, Sadaf MI, Enriquez AD, Freeman JV, Akar JG.

Circ Arrhythm Electrophysiol. 2018 Dec;11(12):e006814. doi: 10.1161/CIRCEP.118.006814. No abstract available. Erratum in: Circ Arrhythm Electrophysiol. 2019 Jan;12(1):e000034.

PMID:
30562101
12.

Can advanced analytics fix modern medicine's problem of uncertainty, imprecision, and inaccuracy?

Ahmad T, Freeman JV, Asselbergs FW.

Eur J Heart Fail. 2019 Jan;21(1):86-89. doi: 10.1002/ejhf.1370. Epub 2018 Dec 10. No abstract available.

13.

Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.

Essien UR, Holmes DN, Jackson LR 2nd, Fonarow GC, Mahaffey KW, Reiffel JA, Steinberg BA, Allen LA, Chan PS, Freeman JV, Blanco RG, Pieper KS, Piccini JP, Peterson ED, Singer DE.

JAMA Cardiol. 2018 Dec 1;3(12):1174-1182. doi: 10.1001/jamacardio.2018.3945.

14.

Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.

Washam JB, Holmes DN, Thomas LE, Pokorney SD, Hylek EM, Fonarow GC, Mahaffey KW, Gersh BJ, Kowey PR, Ansell JE, Go AS, Reiffel JA, Freeman JV, Singer DE, Naccarelli G, Blanco R, Peterson ED, Piccini JP.

J Am Heart Assoc. 2018 Sep 18;7(18):e008928. doi: 10.1161/JAHA.118.008928.

15.

Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA2DS2-VASc Scores: Findings From the ORBIT-AF I and II Registries.

Jackson LR 2nd, Kim S, Fonarow GC, Freeman JV, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Singer D, Thomas L, Blanco R, Peterson ED, Piccini JP Sr; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation Patients and Investigators.

J Am Heart Assoc. 2018 Aug 21;7(16):e008764. doi: 10.1161/JAHA.118.008764.

16.

B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation.

Inohara T, Kim S, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators.

Heart. 2019 Mar;105(5):370-377. doi: 10.1136/heartjnl-2018-313642. Epub 2018 Sep 18.

PMID:
30228248
17.

Response to: "Enlisting Emergency Medicine Clinicians to Help Reduce Strokes in High-Risk Patients With Atrial Fibrillation and Flutter".

Hsu JC, Freeman JV.

Clin Pharmacol Ther. 2018 Oct;104(4):615. doi: 10.1002/cpt.1143. Epub 2018 Jul 14. No abstract available.

PMID:
30006932
18.

Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.

Durheim MT, Holmes DN, Blanco RG, Allen LA, Chan PS, Freeman JV, Fonarow GC, Go AS, Hylek EM, Mahaffey KW, Pokorney SD, Reiffel JA, Singer DE, Peterson ED, Piccini JP.

Heart. 2018 Nov;104(22):1850-1858. doi: 10.1136/heartjnl-2017-312735. Epub 2018 Jun 6.

PMID:
29875139
19.

Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.

O'Brien EC, Holmes DN, Thomas LE, Fonarow GC, Allen LA, Gersh BJ, Kowey PR, Singer DE, Ezekowitz MD, Naccarelli GV, Ansell JE, Chan PS, Mahaffey KW, Go AS, Freeman JV, Reiffel JA, Peterson ED, Piccini JP, Hylek EM.

Circulation. 2018 Aug 28;138(9):889-897. doi: 10.1161/CIRCULATIONAHA.117.031354.

PMID:
29678813
20.

Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry.

Friedman DJ, Parzynski CS, Heist EK, Russo AM, Akar JG, Freeman JV, Curtis JP, Al-Khatib SM.

Circulation. 2018 Jun 5;137(23):2463-2477. doi: 10.1161/CIRCULATIONAHA.117.032167. Epub 2018 Feb 20.

21.

Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).

Steinberg BA, Shrader P, Pieper K, Thomas L, Allen LA, Ansell J, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli GV, Reiffel JA, Singer DE, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBITā€AF) II Investigators.

J Am Heart Assoc. 2018 Feb 16;7(4). pii: e007633. doi: 10.1161/JAHA.117.007633.

22.

Contemporary Procedural Complications, Hospitalizations, and Emergency Visits After Catheter Ablation for Atrial Fibrillation.

Freeman JV, Tabada GH, Reynolds K, Sung SH, Liu TI, Gupta N, Go AS.

Am J Cardiol. 2018 Mar 1;121(5):602-608. doi: 10.1016/j.amjcard.2017.11.034. Epub 2017 Dec 14.

23.

Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review.

Hsu JC, Freeman JV.

Clin Pharmacol Ther. 2018 Aug;104(2):301-310. doi: 10.1002/cpt.1024. Epub 2018 Feb 13. Review.

PMID:
29328506
24.

Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation).

Barnett AS, Kim S, Fonarow GC, Thomas LE, Reiffel JA, Allen LA, Freeman JV, Naccarelli G, Mahaffey KW, Go AS, Kowey PR, Ansell JE, Gersh BJ, Hylek EM, Peterson ED, Piccini JP.

Circ Arrhythm Electrophysiol. 2017 Nov;10(11). pii: e005051. doi: 10.1161/CIRCEP.117.005051.

PMID:
29141842
25.

Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study.

Inohara T, Shrader P, Pieper K, Blanco RG, Thomas L, Singer DE, Freeman JV, Allen LA, Fonarow GC, Gersh B, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Steinberg BA, Peterson ED, Piccini JP.

JAMA Cardiol. 2018 Jan 1;3(1):54-63. doi: 10.1001/jamacardio.2017.4665.

26.

Remote monitoring of implantable cardiac devices: current state and future directions.

Ganeshan R, Enriquez AD, Freeman JV.

Curr Opin Cardiol. 2018 Jan;33(1):20-30. doi: 10.1097/HCO.0000000000000471. Review.

PMID:
29059076
27.

Barriers to the success of an electronic pharmacovigilance reporting system in Kenya: an evaluation three years post implementation.

Agoro OO, Kibira SW, Freeman JV, Fraser HSF.

J Am Med Inform Assoc. 2018 Jun 1;25(6):627-634. doi: 10.1093/jamia/ocx102.

28.

Can machine learning complement traditional medical device surveillance? A case study of dual-chamber implantable cardioverter-defibrillators.

Ross JS, Bates J, Parzynski CS, Akar JG, Curtis JP, Desai NR, Freeman JV, Gamble GM, Kuntz R, Li SX, Marinac-Dabic D, Masoudi FA, Normand ST, Ranasinghe I, Shaw RE, Krumholz HM.

Med Devices (Auckl). 2017 Aug 16;10:165-188. doi: 10.2147/MDER.S138158. eCollection 2017.

29.

Disease understanding in patients newly diagnosed with atrial fibrillation.

Kaufman BG, Kim S, Pieper K, Allen LA, Gersh BJ, Naccarelli GV, Ezekowitz MD, Fonarow GC, Mahaffey KW, Singer DE, Chan PS, Freeman JV, Ansell J, Kowey PR, Rieffel JA, Piccini J, Peterson E, O'Brien EC.

Heart. 2018 Mar;104(6):494-501. doi: 10.1136/heartjnl-2017-311800. Epub 2017 Aug 8.

30.

Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.

Black-Maier E, Kim S, Steinberg BA, Fonarow GC, Freeman JV, Kowey PR, Ansell J, Gersh BJ, Mahaffey KW, Naccarelli G, Hylek EM, Go AS, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators.

Clin Cardiol. 2017 Sep;40(9):746-751. doi: 10.1002/clc.22726. Epub 2017 May 19.

31.

Hovering and Swarming Behavior of Male Tabanus calens (Diptera: Tabanidae) in Tennessee and New Jersey, USA.

Mullens BA, Freeman JV.

J Med Entomol. 2017 Sep 1;54(5):1410-1414. doi: 10.1093/jme/tjx070.

PMID:
28399285
32.

National Trends in Atrial Fibrillation Hospitalization, Readmission, and Mortality for Medicare Beneficiaries, 1999-2013.

Freeman JV, Wang Y, Akar J, Desai N, Krumholz H.

Circulation. 2017 Mar 28;135(13):1227-1239. doi: 10.1161/CIRCULATIONAHA.116.022388. Epub 2017 Feb 1.

PMID:
28148599
33.

Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation.

Hess PL, Kim S, Fonarow GC, Thomas L, Singer DE, Freeman JV, Gersh BJ, Ansell J, Kowey PR, Mahaffey KW, Chan PS, Steinberg BA, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Patients and Investigators.

Am J Med. 2017 Apr;130(4):449-456. doi: 10.1016/j.amjmed.2016.11.001. Epub 2016 Nov 23.

34.

Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.

Freeman JV, Hutton DW, Barnes GD, Zhu RP, Owens DK, Garber AM, Go AS, Hlatky MA, Heidenreich PA, Wang PJ, Al-Ahmad A, Turakhia MP.

Circ Arrhythm Electrophysiol. 2016 Jun;9(6). pii: e003407. doi: 10.1161/CIRCEP.115.003407.

35.

Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation: An Observational Cohort Study.

Ranasinghe I, Parzynski CS, Freeman JV, Dreyer RP, Ross JS, Akar JG, Krumholz HM, Curtis JP.

Ann Intern Med. 2016 Jul 5;165(1):20-29. doi: 10.7326/M15-2732. Epub 2016 May 3.

PMID:
27135392
36.

How to spot a statistical problem: advice for a non-statistical reviewer.

Greenwood DC, Freeman JV.

BMC Med. 2015 Nov 2;13:270. doi: 10.1186/s12916-015-0510-5.

37.

Effectiveness of the Kids in Control of Food (KICk-OFF) structured education course for 11-16 year olds with Type 1 diabetes.

Price KJ, Knowles JA, Fox M, Wales JK, Heller S, Eiser C, Freeman JV; KICk-OFF Study group.

Diabet Med. 2016 Feb;33(2):192-203. doi: 10.1111/dme.12881. Epub 2015 Sep 9.

PMID:
26248789
38.

Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Freeman JV, Simon DN, Go AS, Spertus J, Fonarow GC, Gersh BJ, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, Chang P, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients.

Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):393-402. doi: 10.1161/CIRCOUTCOMES.114.001303. Epub 2015 Jun 9.

PMID:
26058720
39.

Remote Monitoring and Outcomes in Pacemaker and Defibrillator Patients: Big Data Saving Lives?

Freeman JV, Saxon L.

J Am Coll Cardiol. 2015 Jun 23;65(24):2611-2613. doi: 10.1016/j.jacc.2015.04.031. Epub 2015 May 13. No abstract available.

40.

Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Holmqvist F, Guan N, Zhu Z, Kowey PR, Allen LA, Fonarow GC, Hylek EM, Mahaffey KW, Freeman JV, Chang P, Holmes DN, Peterson ED, Piccini JP, Gersh BJ; ORBIT-AF Investigators.

Am Heart J. 2015 May;169(5):647-654.e2. doi: 10.1016/j.ahj.2014.12.024. Epub 2015 Feb 7.

41.

Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF).

Turakhia MP, Ullal AJ, Hoang DD, Than CT, Miller JD, Friday KJ, Perez MV, Freeman JV, Wang PJ, Heidenreich PA.

Clin Cardiol. 2015 May;38(5):285-92. doi: 10.1002/clc.22387. Epub 2015 Apr 14.

42.

Heart rate is associated with progression of atrial fibrillation, independent of rhythm.

Holmqvist F, Kim S, Steinberg BA, Reiffel JA, Mahaffey KW, Gersh BJ, Fonarow GC, Naccarelli GV, Chang P, Freeman JV, Kowey PR, Thomas L, Peterson ED, Piccini JP; ORBIT-AF Investigators.

Heart. 2015 Jun;101(11):894-9. doi: 10.1136/heartjnl-2014-307043. Epub 2015 Mar 2.

43.

Esthetic judgments of palatally displaced canines 3 months postdebond after surgical exposure with either a closed or an open technique.

Parkin NA, Freeman JV, Deery C, Benson PE.

Am J Orthod Dentofacial Orthop. 2015 Feb;147(2):173-81. doi: 10.1016/j.ajodo.2014.10.026.

44.

Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.

Freeman JV, Reynolds K, Fang M, Udaltsova N, Steimle A, Pomernacki NK, Borowsky LH, Harrison TN, Singer DE, Go AS.

Circ Arrhythm Electrophysiol. 2015 Feb;8(1):49-58. doi: 10.1161/CIRCEP.114.002292. Epub 2014 Nov 20.

45.

Factors perceived to influence risky sexual behaviours among university students in the United Kingdom: a qualitative telephone interview study.

Chanakira E, O'Cathain A, Goyder EC, Freeman JV.

BMC Public Health. 2014 Oct 9;14:1055. doi: 10.1186/1471-2458-14-1055.

46.

Social and psychosocial factors associated with high-risk sexual behaviour among university students in the United Kingdom: a web-survey.

Chanakira E, Goyder EC, Freeman JV, O'Cathain A, Kinghorn G, Jakubovic M.

Int J STD AIDS. 2015 May;26(6):369-78. doi: 10.1177/0956462414538950. Epub 2014 Jun 9.

PMID:
24912538
47.

Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure.

Freeman JV, Yang J, Sung SH, Hlatky MA, Go AS.

Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):525-33. doi: 10.1161/CIRCOUTCOMES.111.000079. Epub 2013 Sep 10.

PMID:
24021697
48.

Periodontal health of palatally displaced canines treated with open or closed surgical technique: a multicenter, randomized controlled trial.

Parkin NA, Milner RS, Deery C, Tinsley D, Smith AM, Germain P, Freeman JV, Bell SJ, Benson PE.

Am J Orthod Dentofacial Orthop. 2013 Aug;144(2):176-84. doi: 10.1016/j.ajodo.2013.03.016.

49.

Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation.

Hess PL, Kim S, Piccini JP, Allen LA, Ansell JE, Chang P, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Fonarow GC.

Am J Med. 2013 Jul;126(7):625-32.e1. doi: 10.1016/j.amjmed.2013.01.037.

50.

Neoadjuvant chemotherapy with or without zoledronic acid in early breast cancer--a randomized biomarker pilot study.

Winter MC, Wilson C, Syddall SP, Cross SS, Evans A, Ingram CE, Jolley IJ, Hatton MQ, Freeman JV, Mori S, Holen I, Coleman RE.

Clin Cancer Res. 2013 May 15;19(10):2755-65. doi: 10.1158/1078-0432.CCR-12-3235. Epub 2013 Mar 20.

Supplemental Content

Loading ...
Support Center